Abstract Recent attention has focused on the antitumor immune response in breast cancer, in particular, the role of tumor-infiltrating lymphocytes (TILs). In certain breast cancer subtypes, the presence of TILs has prognostic value and is associated with clinical outcome and improved survival. The potential predictive value of TILs has also been investigated in regard to cytotoxic and antihuman epidermal growth factor receptor 2 (HER-2) therapies, but could also serve as a selection marker for novel immunotherapies. In this article, we review the current literature on TILs in breast cancer and discuss how TILs are emerging as a promising biomarker in mediating antitumor immunity.
antitumor           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Chemotherapy          

immunotherapies               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Immunotherapy         

immunity                      0.9999999951521659^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Immune_system         

antitumor                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Chemotherapy          

breast cancer                 0.9995954167574055^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Breast_cancer         

breast cancer                 0.9995954167574055^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Breast_cancer         

tumor-infiltrating lymphocytes1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Tumor-infiltrating_lymphocytes

current literature            0.9999999992379571^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Current_Literature    

cytotoxic                     0.9999750779395199^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cytotoxicity          

breast cancer                 0.9995954167574055^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Breast_cancer         

prognostic                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Prognosis             

HER-2                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/HER2/neu              

biomarker                     0.9995635755966841^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Biomarker             

immune response               0.9999992734639501^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Immune_system         

epidermal growth factor receptor1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Epidermal_growth_factor_receptor

